The functional benefit of anti-inflammatory aerosols in the lung periphery
- 31 August 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 118 (2) , 340-346
- https://doi.org/10.1016/j.jaci.2006.04.056
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonideRespiratory Medicine, 2005
- Physiologic correlates of distal lung inflammation in asthmaJournal of Allergy and Clinical Immunology, 2004
- The Role of the Distal Lung in AsthmaSeminars in Respiratory and Critical Care Medicine, 2002
- Comparison of Hydrofluoroalkane-Beclomethasone Dipropionate AutohalerTM with Budesonide TurbuhalerTM in Asthma ControlRespiration, 2001
- Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosolAnnals of Allergy, Asthma & Immunology, 2001
- The comparative safety/efficacy ratio of HFA-BDPRespiratory Medicine, 2000
- Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humansJournal of Allergy and Clinical Immunology, 1999
- Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellantJournal of Allergy and Clinical Immunology, 1999
- Effect of Inhalation Flow Rate on the Dosing Characteristics of Dry Powder Inhaler (DPI) and Metered Dose Inhaler (MDI) ProductsJournal of Aerosol Medicine, 1996
- Lung deposition of budesonide inhaled via Turbuhaler: a comparison with terbutaline sulphate in normal subjectsEuropean Respiratory Journal, 1994